• 135463+ Medical Conferences
  • 251 Specialties
  • 10418 Organizers
  • 150771 Speakers
  • 155 Countries
  • 4526 Cities
CME Conference Registrations Sold
Home  >  Speakers  >  Abhishek Kulshrestha
Abhishek Kulshrestha

Abhishek Kulshrestha

    BSc, MSc, PhD
Chief, Associate Director | Bengaluru, Karnataka    India
Biotechnology, Biochemistry,...More
Spoken at 2 events

Biography :

Abhishek is working as Principal scientific Manager at Biocon. In Biocon, he leads the Biosimilar recombinant human Insulin program for regulated markets. He also leads the bioanalytical functions related to Pharmacokinetics, Immunogenicity and HCP assessment. With close to 10 years of industry experience in biosimilar and biologics development, he has successfully led research teams working on phage display based antibody libraries, mammalian and bacterial cell line development, bioassays and bioanalytical development.
Abhishek has a PhD in Biochemistry from University of Delhi. The work he performed contributed to commercialization of immuno-diagnostic kits which have won various national awards. After a post-doctoral training at National Technological University (Singapore), he joined Reliance Life Sciences (India) to setup and lead Biosimilar monoclonal antibodies and blood product development. The work led to commercialisation of biosimilars in Indian markets of Abciximab (AbcixiRel), Rituximab (RituxiRel), Trastuzumab (TrastiRel), Adalimumab (AdaliRel) and Bevacizumab (BevaciRel).

*** ** **** **** * ** ** **** ****
For speaker's contact information - Contact us



Interested Topics

Biotechnology, Biochemistry, Monoclonal Antibodies, Protein Expression, Protein Chemistry, Molecular Biology, Cell Culture, Drug Discovery, Life Sciences, Cell Biology

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.


English, Spanish

Conference Session Materials

The conference session material has yet to be added by the speaker.

Send Message